x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Global Oncology Academy

The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments. For more information about GOA, visit www.globaloncologyacademy.org.

science & medicine medicine

All Episodes

00:00:00

Navigating NUT Carcinoma: Diagnosis and Treatment...

Global Oncology Academy ·

2023/09/05

Host: Jacob Sands, MD Guest: Jia Luo, MD NUT carcinoma is a rare, aggressive form of cancer that’s highly resistant to therapy and has no defined standard treatment. Joining Dr. Jacob Sands to discuss the best diagnostic and treatment strategies for NUT carcinoma is Dr. Jia Luo, medical oncologist at Dana-Farber Cancer Institute and an Instructor of Medicine at Harvard Medical School in Boston.

en

00:00:00

Optimizing Quality & Safety Systems to Reduce the...

Global Oncology Academy ·

2023/05/30

Host: Jacob Sands, MD Guest: Joseph O. Jacobson, MD Over the past few decades, increasing attention has been placed on reducing the risk of patient harm within the healthcare system. Learn more about the risks that are specific to medical oncology and how current systems are addressing them with Dr. Jacob Sands and Dr. Joseph Jacobson, Senior Advisor for Quality and Patient Safety at Dana-Farber Cancer Institute.

en

00:00:00

Exploring New Frontiers in Cervical Cancer Screening

Global Oncology Academy ·

2023/01/25

Host: Jennifer Caudle, DO Guest: Diane M. Harper, MD, MPH, MS There are several testing methods available for cervical cancer screening, such as co-testing and primary HPV testing. So what are some of the most prominent benefits and limitations of these and other testing approaches? Joining Dr. Jennifer Caudle to break down the latest advancements in cervical cancer screening is Dr. Diane Harper, a Professor in the Departments of Family Medicine and Obstetrics and Gynecology at the

en

00:00:00

HER2-Directed ADCs in Breast Cancer

Global Oncology Academy ·

2022/06/30

Guest: Sara A. Hurvitz, MD, FACP

en

00:00:00

Conversations Around Chemotherapy: Do All of Your...

Global Oncology Academy ·

2022/05/13

Host: Pavani Chalasani, MD, MPH Guest: Kevin Kalinsky MD, MS Chemotherapy is one of the most commonly used treatments for cancer—but it can lead to challenging side effects. So do all of our patients really need it? Joining Dr. Pavani Chalasani to discuss whether or not chemotherapy is the right choice for patients with hormone receptor-positive HER2-negative, node-positive breast cancer is Dr. Kevin Kalinsky from Emory University.

en

00:00:00

Hepatocellular Carcinoma: Evaluating the Evolving...

Global Oncology Academy ·

2022/03/24

Host: Jacob Sands, MD Guest: Manish A. Shah, MD FASCO For patients with unresectable liver-limited hepatocellular carcinoma, treatment can be challenging. Clinicians typically care for these patients with local-regional therapies, but is that the best option for all of them? To answer this question, Dr. Jacob Sands joins Dr. Manish Shah from Weill Cornell Medicine to take a look at current and emerging strategies for managing and treating unresectable liver-limited hepatocellular

en

00:00:00

Closing the Gaps in Cancer Screening: Insights from...

Global Oncology Academy ·

2022/03/17

Host: Jacob Sands, MD Guest: Edith Mitchell, MD, MACP, FCPP, FRCP Appointed member to the President's Cancer Panel and Clinical Professor of Medicine at Thomas Jefferson University, Dr. Edith Mitchell, shares what the panel recommends to close gaps in cancer screening in the U.S.—with a focus on colorectal cancer—to improve access for all patients.

en

00:00:00

Pediatric Oncofertility: Key Considerations & Procedures

Global Oncology Academy ·

2022/01/12

Host: Jacob Sands, MD Guest: Yasmin Jayasinghe, FRANZCOG, PhD Pediatric and adolescent oncofertility patients are cared for differently than adult patients. That’s why Dr. Yasmin Jayasinghe, Director of the Oncofertility Program at the Royal Children’s Hospital, is here to give us an overview of the available procedures for pediatric patients and the key considerations that go along with them.

en

00:00:00

A Global View of Oncofertility: Lessons Learned from...

Global Oncology Academy ·

2022/01/12

Host: Jacob Sands, MD Guest: Yasmin Jayasinghe, FRANZCOG, PhD Cancer treatment can impact fertility outcomes for individuals throughout the U.S. as well as around the globe, which is why the emerging field of oncofertility is here to help male and female patients navigate their fertility options before and after their cancer treatments. So what can we learn from oncofertility services and efforts from other countries around the world? Joining Dr. Jacob Sands to share her global

en

00:00:00

A Look at the Emerging Field of Oncofertility

Global Oncology Academy ·

2021/12/20

Host: Jacob Sands, MD Guest: Suneeta Senapati, MD, MSCE Guest: Mindy Christianson, MD Patients undergoing treatments such as chemotherapy may be at significant risk of impairment or inability to have children later in life. This risk impacts both men and women equally, but fortunately, the field of oncofertility can help guide patients as they navigate their fertility options prior to cancer treatment. Here to share their insights on this emerging field with Dr. Jacob Sands are

en

00:00:00

Exploring EGFR Mutations in Lung Cancer: Key...

Global Oncology Academy ·

2021/03/18

Host: Jacob Sands, MD Guest: Pasi Antero Jänne, MD, PhD Once we’ve confirmed a patient has EGFR-mutated lung cancer, how can we treat them? Joining Dr. Jacob Sands to discuss the current and future treatments for this mutation is Dr. Pasi Janne, a translational thoracic medical oncologist at the Dana-Farber Cancer Institute.

en

00:00:00

Cancer Care During the COVID-19 Pandemic

Global Oncology Academy ·

2021/01/22

Host: Jacob Sands, MD How has cancer care changed from the initial outbreak of the COVID-19 pandemic? Dr. Jacob Sands, Thoracic Medical Oncologist at the Dana-Farber Institute in Boston, shares how he has been treating his patients during the COVID-19 pandemic.

en

00:00:00

Confronting the Disparity Crisis in Breast Cancer Care

Global Oncology Academy ·

2021/01/15

Guest: Mariana Chavez MacGregor, MD, MSC The healthcare disparity crisis in the breast cancer field has prevented the benefits of therapeutic advancements from being equally distributed throughout all populations. What can we do to overcome this obstacle? Dr. Mariana Chavez MacGregor, Associate Professor at the University of Texas MD Anderson Cancer Center, talks about the disparities she's encountered in breast cancer care.

en

00:00:00

Exploring the Impacts of Race & Bias in Cancer Treatment

Global Oncology Academy ·

2021/01/12

Host: Jacob Sands, MD Guest: Christopher Lathan, MD, MS, MPH Oftentimes, a patient’s zip code is a better indicator of health than blood pressure or genetics, highlighting a significant disparity among communities. How are barriers such as systemic racism contributing to this disparity, and what can we do to change that? Dr. Jacob Sands is joined by Dr. Christopher Lathan to discuss medical disparities as a result of systemic racism.

en

00:00:00

Systemic Racism & Disparities in Oncology

Global Oncology Academy ·

2021/01/12

Guest: Christopher Lathan, MD, MS, MPH Healthcare professionals have found that zip code is a better indicator of health for many patients rather than cholesterol or genetics, highlighting a significant disparity in the field of medicine. What can we do to overcome this obstacle? Dr. Christopher Lathan, Associate Medical Director of the Dana Farber Cancer Institute Network, explains how we can better connect with our patients to improve their care.

en

00:00:00

Cardio-Oncology: An Emerging Field to Improve...

Global Oncology Academy ·

2020/05/14

Host: Jennifer Caudle, DO Guest: Kathryn J. Ruddy, MD Guest: Joerg Herrmann, MD As the number of cancer survivors continues to grow due to treatment advances, so too do the long-term impacts like cardiovascular complications. That’s why the field of cardio-oncology has emerged, and to learn more, Dr. Jennifer Caudle speaks with Drs. Kathryn Ruddy and Joerg Herrmann from the cardio-oncology clinic at the Mayo Clinic to talk about the field that’s devoted to improving

en

00:00:00

HIPEC: A Novel Treatment for Advanced Abdominal Cancers

Global Oncology Academy ·

2020/01/23

Host: John Russell, MD Guest: Nabil Wasif, MD Image: Mayo Foundation For Medical Education and Research. All Rights Reserved. Short for hyperthermic intraperitoneal chemotherapy, HIPEC is a form of treatment for advanced cancers of the gastrointestinal tract, like metastatic appendix, colon, and ovarian cancers. And after a recent Mayo Clinic study investigated the survival rates of patients who received HIPEC, Dr. Nabil Wasif joins us to discuss the study’s results as well as the

en

00:00:00

What to Know About a State-of-the-Art Approach to...

Global Oncology Academy ·

2018/01/17

Host: Shira Johnson, MD Guest: Ronald DeMatteo, MD, FACS A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate in the United States of approximately 4,000 to 6,000 cases per year. Since these tumors behave differently from other gastrointestinal cancers, they require a specialized treatment plan. Host Dr. Shira Johnson chats with Ronald DeMatteo, MD, FACS, Chair of the Department of Surgery and a surgical

en

00:00:00

Pancreatic Cancer: The Hunt to Catch a Silent Killer

Global Oncology Academy ·

2017/08/12

Host: John Russell, MD Guest: Harish Lavu, MD Pancreatic cancer is projected to become the second leading cause of cancer-related death in the United States by 2020. This is due, in large part, to its insidious onset and subtle presentation even at late stages, many symptoms of which are often attributed to common and less serious conditions in aging populations. Dr. Harish Lavu, Head of Hepatopancreatobiliary Surgery at Jefferson University, talks with host Dr. John Russell about

en

00:00:00

The CAM Guide to Cancer: An Integrative Approach to...

Global Oncology Academy ·

2017/07/17

Host: Kathy King, RDN Guest: Lise Alschuler, ND Host Kathy King sits down with Dr. Lise Alschuler, naturopathic doctor, cancer survivor, and author of The Definitive Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing. Dr. Alschuler is co-founder of iTHRIVEplan.com, a web application providing personalized wellness plans tailored to cancer survivors. They talk about how integrative medicine specialists approach cancer: its causes, prevention strategies,

en

83 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事